Alnylam Pharmaceuticals (ALNY) Return on Capital Employed Growth (5y) (2015 - 2026)
Alnylam Pharmaceuticals (ALNY) Return on Capital Employed Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 37.23 Bn | 37.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,870.00 |
| Dec 31, 2025 | 4,446.00 |
| Sep 30, 2025 | 4,099.00 |
| Jun 30, 2025 | 3,197.00 |
| Mar 31, 2025 | 4,441.00 |
| Dec 31, 2024 | 3,858.00 |
| Sep 30, 2024 | 3,134.00 |
| Jun 30, 2024 | 4,778.00 |
| Mar 31, 2024 | 4,594.00 |
| Dec 31, 2023 | 4,651.00 |
| Sep 30, 2023 | 3,277.00 |
| Jun 30, 2023 | 349.00 |
| Mar 31, 2023 | 115.00 |
| Dec 31, 2022 | 433.00 |
| Sep 30, 2022 | 641.00 |
| Jun 30, 2022 | 1,198.00 |
| Mar 31, 2022 | 1,537.00 |
| Dec 31, 2021 | 1,196.00 |
| Sep 30, 2021 | 714.00 |
| Jun 30, 2021 | 260.00 |